Back to search

Boston University

3D culture platform for the study of cancer biology and drug response

Abstract

dc:description.abstract

Cancer is the third leading cause of death worldwide, accounting for almost 13% of all mortalities. In developed countries, when caught early, cancer is very treatable with high success rates for first line treatments. In fact, only about 10% of cancer-related deaths are due to the primary tumor, with the other 90% being caused by metastatic or recurrent neoplasms. These secondary tumors often present with a reduced sensitivity to chemotherapeutic agents, making treatment difficult. Recently, the role of the cell microenvironment in informing tumor drug response has begun to be appreciated. Despite this, we still lack a comprehensive understanding of this relationship, mostly due to the lack of appropriate in vitro models in which to study cancer-matrix interactions. With the goal of providing insight to such behaviors, the presented research seeks to elucidate the following questions: (1) What effect does a 3D ECM have on cancer cell drug response, both at a cell behavior and protein level? (2) Can we promote in vivo-like cell-cell and cell-ECM interactions in a biomimetic 3D environment? (3) Does a collagen-based 3D culture system recapitulate tissue-specific behaviors of tumor cells? And (4) Can we model disease progression by modulating ECM characteristics? The presented research attempts to first establish the value of 3D culture systems as a model for cancer study, and then use this knowledge to develop and validate a novel, biomimetic cancer cell culture platform. In short, cancer cells are grown into large spheroids and then implanted into type 1 collagen gels. Advanced fluorescent microscopy and protein assays are used to assess cell behavior and drug response. Results indicate that by modulating the collagen content of the gels, cell behavior can be directly controlled, and that the resultant cell behavior is consistent with previous in vivo studies that employed a similar microenvironment. Finally, we show that increasing collagen content can be used as a model of breast cancer progression, including developing insights into later stage tumors with invasive properties.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biomedical Engineering and Pharmacology and Experimental Therapeutics
Grantor dc:publisher
Boston University
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Fallica, Brian

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/10987

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Fallica, Brian. 3D culture platform for the study of cancer biology and drug response. doctoral thesis, Boston University, 2014. https://hdl.handle.net/2144/10987